company background image
1099 logo

Sinopharm Group SEHK:1099 Rapporto sulle azioni

Ultimo prezzo

HK$18.76

Cap. di mercato

HK$58.5b

7D

-4.8%

1Y

-14.5%

Aggiornato

22 Aug, 2024

Dati

Dati finanziari dell'azienda +

Sinopharm Group Co. Ltd.

SEHK:1099 Rapporto sulle azioni

Cap. di mercato: HK$58.5b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

1099 Panoramica delle azioni

Sinopharm Group Co. Ltd., insieme alle sue consociate, si occupa della vendita all'ingrosso e al dettaglio di prodotti farmaceutici, dispositivi medici e prodotti sanitari nella Repubblica Popolare Cinese.

Informazioni sull'azienda

1099 analisi fondamentale
Punteggio fiocco di neve
Valutazione6/6
Crescita futura1/6
Prestazioni passate2/6
Salute finanziaria4/6
Dividendi5/6

Premi

Negoziato a 50.5% al di sotto della nostra stima del suo valore equo
Si prevede che gli utili cresceranno del 6.69% all'anno
Gli utili sono cresciuti del 9% all'anno negli ultimi 5 anni
Paga un dividendo affidabile di 4.87%
Negoziato a un buon valore rispetto ai pari e al settore
Gli analisti concordano sul fatto che il prezzo delle azioni salirà di 35.6%

Analisi del rischio

Non sono stati rilevati rischi per 1099 dai nostri controlli di rischio.

Sinopharm Group Co. Ltd. Concorrenti

Guangzhou Baiyunshan Pharmaceutical Holdings

SEHK:874

HK$48.9b

Shanghai Pioneer Holding

SEHK:1345

HK$2.4b

Tycoon Group Holdings

SEHK:3390

HK$3.0b

IVD Medical Holding

SEHK:1931

HK$1.1b

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Sinopharm Group
Prezzi storici delle azioni
Prezzo attuale dell'azioneHK$18.76
Massimo di 52 settimaneHK$23.20
Minimo di 52 settimaneHK$17.44
Beta0.86
1Variazione di 1 mese-0.64%
Variazione a 3 mesi-11.92%
Variazione di 1 anno-14.53%
3Variazione a 3 anni-1.68%
Variazione a 5 anni-32.76%
Variazione dall'IPO1.30%

Notizie e aggiornamenti recenti

The Market Doesn't Like What It Sees From Sinopharm Group Co. Ltd.'s (HKG:1099) Earnings Yet

Jul 27
The Market Doesn't Like What It Sees From Sinopharm Group Co. Ltd.'s (HKG:1099) Earnings Yet

Sinopharm Group (HKG:1099) Is Increasing Its Dividend To CN¥0.956

Jun 16
Sinopharm Group (HKG:1099) Is Increasing Its Dividend To CN¥0.956

Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 46% Discount?

May 13
Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 46% Discount?

Recent updates

The Market Doesn't Like What It Sees From Sinopharm Group Co. Ltd.'s (HKG:1099) Earnings Yet

Jul 27
The Market Doesn't Like What It Sees From Sinopharm Group Co. Ltd.'s (HKG:1099) Earnings Yet

Sinopharm Group (HKG:1099) Is Increasing Its Dividend To CN¥0.956

Jun 16
Sinopharm Group (HKG:1099) Is Increasing Its Dividend To CN¥0.956

Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 46% Discount?

May 13
Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 46% Discount?

Is Sinopharm Group (HKG:1099) A Risky Investment?

Apr 22
Is Sinopharm Group (HKG:1099) A Risky Investment?

Investors Could Be Concerned With Sinopharm Group's (HKG:1099) Returns On Capital

Mar 21
Investors Could Be Concerned With Sinopharm Group's (HKG:1099) Returns On Capital

Should You Think About Buying Sinopharm Group Co. Ltd. (HKG:1099) Now?

Mar 06
Should You Think About Buying Sinopharm Group Co. Ltd. (HKG:1099) Now?

Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 29% Discount?

Jan 31
Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 29% Discount?

Is Sinopharm Group (HKG:1099) A Risky Investment?

Jan 15
Is Sinopharm Group (HKG:1099) A Risky Investment?

There Is A Reason Sinopharm Group Co. Ltd.'s (HKG:1099) Price Is Undemanding

Dec 31
There Is A Reason Sinopharm Group Co. Ltd.'s (HKG:1099) Price Is Undemanding

Returns On Capital Signal Tricky Times Ahead For Sinopharm Group (HKG:1099)

Nov 29
Returns On Capital Signal Tricky Times Ahead For Sinopharm Group (HKG:1099)

If EPS Growth Is Important To You, Sinopharm Group (HKG:1099) Presents An Opportunity

Nov 14
If EPS Growth Is Important To You, Sinopharm Group (HKG:1099) Presents An Opportunity

Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 28% Discount?

Nov 01
Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 28% Discount?

Should You Investigate Sinopharm Group Co. Ltd. (HKG:1099) At HK$22.45?

Sep 20
Should You Investigate Sinopharm Group Co. Ltd. (HKG:1099) At HK$22.45?

Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Sep 05
Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Returns On Capital At Sinopharm Group (HKG:1099) Have Stalled

Aug 18
Returns On Capital At Sinopharm Group (HKG:1099) Have Stalled

Are Sinopharm Group Co. Ltd. (HKG:1099) Investors Paying Above The Intrinsic Value?

Aug 02
Are Sinopharm Group Co. Ltd. (HKG:1099) Investors Paying Above The Intrinsic Value?

Sinopharm Group (HKG:1099) Seems To Use Debt Quite Sensibly

Jun 01
Sinopharm Group (HKG:1099) Seems To Use Debt Quite Sensibly

Sinopharm Group's (HKG:1099) Returns Have Hit A Wall

Apr 26
Sinopharm Group's (HKG:1099) Returns Have Hit A Wall

These 4 Measures Indicate That Sinopharm Group (HKG:1099) Is Using Debt Reasonably Well

Feb 27
These 4 Measures Indicate That Sinopharm Group (HKG:1099) Is Using Debt Reasonably Well

Sinopharm Group (HKG:1099) Has Some Way To Go To Become A Multi-Bagger

Jan 19
Sinopharm Group (HKG:1099) Has Some Way To Go To Become A Multi-Bagger

Is Sinopharm Group (HKG:1099) A Risky Investment?

Nov 18
Is Sinopharm Group (HKG:1099) A Risky Investment?

Returns At Sinopharm Group (HKG:1099) Appear To Be Weighed Down

Oct 03
Returns At Sinopharm Group (HKG:1099) Appear To Be Weighed Down

Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Jul 31
Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Estimating The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)

Jul 10
Estimating The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)

Slowing Rates Of Return At Sinopharm Group (HKG:1099) Leave Little Room For Excitement

Jun 05
Slowing Rates Of Return At Sinopharm Group (HKG:1099) Leave Little Room For Excitement

We Think Sinopharm Group (HKG:1099) Can Stay On Top Of Its Debt

Apr 11
We Think Sinopharm Group (HKG:1099) Can Stay On Top Of Its Debt

A Look At The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)

Mar 21
A Look At The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)

Sinopharm Group (HKG:1099) Hasn't Managed To Accelerate Its Returns

Mar 03
Sinopharm Group (HKG:1099) Hasn't Managed To Accelerate Its Returns

Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Jan 09
Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Sinopharm Group Co., Ltd.'s (HKG:1099) Intrinsic Value Is Potentially 28% Above Its Share Price

Dec 19
Sinopharm Group Co., Ltd.'s (HKG:1099) Intrinsic Value Is Potentially 28% Above Its Share Price

Returns On Capital At Sinopharm Group (HKG:1099) Have Stalled

Dec 01
Returns On Capital At Sinopharm Group (HKG:1099) Have Stalled

These 4 Measures Indicate That Sinopharm Group (HKG:1099) Is Using Debt Reasonably Well

Sep 23
These 4 Measures Indicate That Sinopharm Group (HKG:1099) Is Using Debt Reasonably Well

A Look At The Fair Value Of Sinopharm Group Co., Ltd. (HKG:1099)

Sep 10
A Look At The Fair Value Of Sinopharm Group Co., Ltd. (HKG:1099)

Return Trends At Sinopharm Group (HKG:1099) Aren't Appealing

Aug 28
Return Trends At Sinopharm Group (HKG:1099) Aren't Appealing

Sinopharm Group (HKG:1099) Is Increasing Its Dividend To HK$0.84

Jun 13
Sinopharm Group (HKG:1099) Is Increasing Its Dividend To HK$0.84

Here's Why Sinopharm Group (HKG:1099) Can Manage Its Debt Responsibly

Jun 06
Here's Why Sinopharm Group (HKG:1099) Can Manage Its Debt Responsibly

Is Sinopharm Group Co., Ltd. (HKG:1099) Expensive For A Reason? A Look At Its Intrinsic Value

May 24
Is Sinopharm Group Co., Ltd. (HKG:1099) Expensive For A Reason? A Look At Its Intrinsic Value

Sinopharm Group's (HKG:1099) Returns Have Hit A Wall

May 11
Sinopharm Group's (HKG:1099) Returns Have Hit A Wall

Have Insiders Been Selling Sinopharm Group Co., Ltd. (HKG:1099) Shares?

Mar 20
Have Insiders Been Selling Sinopharm Group Co., Ltd. (HKG:1099) Shares?

We Think Sinopharm Group (HKG:1099) Is Taking Some Risk With Its Debt

Mar 05
We Think Sinopharm Group (HKG:1099) Is Taking Some Risk With Its Debt

You Have To Love Sinopharm Group Co., Ltd.'s (HKG:1099) Dividend

Feb 18
You Have To Love Sinopharm Group Co., Ltd.'s (HKG:1099) Dividend

Should You Be Impressed By Sinopharm Group's (HKG:1099) Returns on Capital?

Feb 03
Should You Be Impressed By Sinopharm Group's (HKG:1099) Returns on Capital?

Should You Use Sinopharm Group's (HKG:1099) Statutory Earnings To Analyse It?

Jan 19
Should You Use Sinopharm Group's (HKG:1099) Statutory Earnings To Analyse It?

At HK$19.00, Is It Time To Put Sinopharm Group Co., Ltd. (HKG:1099) On Your Watch List?

Jan 06
At HK$19.00, Is It Time To Put Sinopharm Group Co., Ltd. (HKG:1099) On Your Watch List?

What Type Of Shareholders Make Up Sinopharm Group Co., Ltd.'s (HKG:1099) Share Registry?

Dec 25
What Type Of Shareholders Make Up Sinopharm Group Co., Ltd.'s (HKG:1099) Share Registry?

Read This Before Buying Sinopharm Group Co., Ltd. (HKG:1099) Shares

Dec 15
Read This Before Buying Sinopharm Group Co., Ltd. (HKG:1099) Shares

We Think Sinopharm Group (HKG:1099) Can Stay On Top Of Its Debt

Dec 04
We Think Sinopharm Group (HKG:1099) Can Stay On Top Of Its Debt

Rendimenti per gli azionisti

1099HK HealthcareHK Mercato
7D-4.8%-1.8%1.3%
1Y-14.5%-30.9%4.2%

Ritorno vs Industria: 1099 ha superato il Hong Kong Healthcare che ha restituito -30.6 % nell'ultimo anno.

Rendimento vs Mercato: 1099 ha avuto una performance inferiore al mercato Hong Kong che ha registrato un rendimento 6.2 % nell'ultimo anno.

Volatilità dei prezzi

Is 1099's price volatile compared to industry and market?
1099 volatility
1099 Average Weekly Movement4.0%
Healthcare Industry Average Movement5.6%
Market Average Movement6.3%
10% most volatile stocks in HK Market13.2%
10% least volatile stocks in HK Market3.4%

Prezzo delle azioni stabile: 1099 non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 4% ) di 1099 è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

FondatoI dipendentiAMMINISTRATORE DELEGATOSito web
2003115,959Yong Liuwww.sinopharmgroup.com.cn

Sinopharm Group Co. Ltd., insieme alle sue controllate, si occupa della vendita all'ingrosso e al dettaglio di prodotti farmaceutici, dispositivi medici e prodotti sanitari nella Repubblica Popolare Cinese. L'azienda opera attraverso quattro segmenti: Distribuzione farmaceutica, Dispositivi medici, Farmacia al dettaglio e Altre attività. Il segmento Distribuzione farmaceutica distribuisce prodotti farmaceutici a ospedali, altri distributori, negozi di farmacia al dettaglio e cliniche.

Sinopharm Group Co. Ltd. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Sinopharm Group con la sua capitalizzazione di mercato?
1099 statistiche fondamentali
Capitalizzazione di mercatoHK$58.54b
Guadagni(TTM)HK$9.70b
Ricavi(TTM)HK$653.44b

6.0x

Rapporto P/E

0.1x

Rapporto P/S

1099 è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
1099 Conto economico (TTM)
RicaviCN¥598.32b
Costo del fatturatoCN¥550.17b
Profitto lordoCN¥48.15b
Altre speseCN¥39.26b
GuadagniCN¥8.88b

Ultimi guadagni dichiarati

Mar 31, 2024

Prossima data di guadagno

Aug 23, 2024

Utile per azione (EPS)2.85
Margine lordo8.05%
Margine di profitto netto1.48%
Rapporto debito/patrimonio netto62.9%

Come si è comportato 1099 nel lungo periodo?

Vedi performance storica e confronto

Dividendi

5.1%

Rendimento attuale del dividendo

31%

Rapporto di remunerazione